Policy & Regulation
25 November 2020 - - Enrolment of 327 patients with mild-to-moderate symptoms of SARS-CoV-2 infection has completed in the global Phase II clinical trial of CT-P59, an anti-COVID-19 monoclonal antibod...
25 November 2020 - - The United States Food and Drug Administration has deferred a decision on the Biologics License Application for DaxibotulinumtoxinA for Injection, an investigational neuromodulato...
25 November 2020 - - The European Commission has approved an agreement to secure 80m doses of mRNA-1273, US-based biotechnology company Moderna, Inc's (NASDAQ: MRNA) vaccine candidate against COV...
25 November 2020 - - The European Commission has approved Opdivo (nivolumab) for the treatment of adults with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinom...
25 November 2020 - - US-based clinical-stage company Vedanta Biosciences has appointed Troy Ignelzi as an independent member of its board of directors, the company said.

Ignelzi has more ...
25 November 2020 - - The US Food and Drug Administration approved Oxlumo (lumasiran) injection for subcutaneous use, the first-ever therapy available for the treatment of primary hyperoxaluria type 1 ...